PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 118 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,561,000 | -1.5% | 158,686 | +9.2% | 0.03% | -16.1% |
| Q4 2016 | $1,585,000 | -29.6% | 145,322 | -9.6% | 0.03% | -22.5% |
| Q3 2016 | $2,251,000 | +403.6% | 160,700 | +152.3% | 0.04% | +344.4% |
| Q2 2016 | $447,000 | +9.0% | 63,700 | 0.0% | 0.01% | +12.5% |
| Q1 2016 | $410,000 | -80.1% | 63,700 | 0.0% | 0.01% | -77.8% |
| Q4 2015 | $2,064,000 | – | 63,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |